康宁杰瑞制药-B · ALPHAMAB ONCOLOGY
Last · HKSEHK$8.77-0.09 (-1.02%)stale · yahoo · 111h ago
MA10MA20MA50
Market capHK$8.5B968.0M sh
P/E · TTM-41.8fwd -126 · eps -0.21 · loss
Beta0.56vs S&P 500
Div yield—annual · TTM
52w range
HK$6.23HK$15.75
Volume434.0Ksession
Issuer
Legal nameALPHAMAB ONCOLOGY · 康宁杰瑞制药-B
HQHong Kong (HK)
ListingHK 9966
ISINKYG0330A1013
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyCNY
Entity registrylei:254900VOW925DTFGNA02
Org ID9900042596
Websitewww.alphamabonc.com
Employees498
AddressAlphamab Oncology 175 Fangzhou Road 215127, Suzhou
| Revenue | ¥566.2M |
|---|---|
| Operating income | ¥-106.5M |
| Operating margin | -18.8% |
| Period | 2025 |
Loading chart…
Upcoming earnings
THU.27AUG
No actuals reported
Period
Jun 2026
Est. EPS
—
Est. revenue
0
Documents
FormReporting forFiledFlags
Showing 5 of 40 filings